Essling Capital

Teknimed SA is a French company specializing in the design, development, and manufacture of innovative biomaterials and medical devices for various surgical applications, including orthopedics, spine surgery, and sports medicine. Founded in 1990 and based in Vic-en-Bigorre, Teknimed produces a diverse range of products, such as synthetic bone substitutes, orthopedic cements, resorbable polymers, and ligaments. The company utilizes advanced manufacturing techniques, including sintering, injection, lyophilization, and chemical synthesis, within its facilities that feature clean rooms, research and development laboratories, and quality control areas. Teknimed's products are distributed globally through a network of distributors, allowing the company to address the clinical needs of surgeons and patients effectively.

Ubi Transport SAS is a technology company specializing in software solutions for the passenger transportation sector. Founded in 2012 and headquartered in Macon, France, with additional offices in Cagnes-sur-Mer, Paris, Chicago, and Montreal, Ubi Transport develops cloud-based platforms that enhance various aspects of transportation management. Their offerings include 2Cloud for data management, 2Place for passenger information systems, 2School for student transportation management, 2Tod for trip booking and dispatching, and 2PlaceJob for employee transport. The company also provides mobile data terminals for drivers and travel cards for passenger validation. Ubi Transport's solutions are designed to facilitate real-time information sharing among drivers, operators, communities, and users, thereby promoting efficiency in school, intercity, urban, and on-demand transport services. Through innovative and agile digital solutions, Ubi Transport has significantly advanced everyday mobility since its inception.